Hyperkalemia associated with cyclosporine (CsA) use in bone marrow transplantation

Bone Marrow Transplantation

Volumn 19, Issue 3, 1997, Pages 289-291

  Fleming, D R ^a,c   Ouseph, R ^b   Herrington, J ^a,d  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Aldosterone; BMT; Cyclosporine; Hyperkalemia

Indexed keywords

ALDOSTERONE; CYCLOSPORIN A;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERKALEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; LEUKEMIA; MALE; PRIORITY JOURNAL;

EID: 0031039553     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700652     Document Type: Article

References (13)

1. Atkinson K. Cyclosporin in bone marrow transplantation. Bone Marrow Transplant 1987; 1: 265-270.
2. Hows JM, Chipping PM, Fairhead S et al. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A. Br J Haematol 1983; 54: 69-78.
3. Pei Y, Richardson R, Greenwood C et al. Extrarenal effect of cyclosporine A on potassium homeostasis in renal transplant recipients. Am J Kid Dis 1993; 22: 314-319.
4. Jones JW, Gruessner RW, Gores PE, Matas AJ. Hypoaldosteronemic hyporeninemic hyperkalemia after renal transplantation. Transplantation 1993; 56: 1013-1015.
5. Kamel KS, Ethier JH, Quaggin S et al. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporin. J Am Soc Nephrol 1992; 2: 1279-1284.
6. Textor SC, Wiesner R, Wilson DJ et al. Systemic and renal hemodynamic differences between FK506 and cyclosporin in liver transplant recipients. Transplantation 1993; 55: 1332-1339.
7. Goldman MH, Barhart G, Mohana-Kumar T et al. Cyclosporin in cardiac transplantation. Surg Clin North Am 1985; 65: 637-659.
8. Marciniak E, Romond EH, Thompson JS, Henslee PJ. Laboratory control in predicting clinical efficacy of T-cell depletion procedures used for graft-versus-host disease. Importance of limiting dilution analysis. Bone Marrow Transplantation 1988; 3: 589-598.
9. Aguilara S, Deray G, Desjobert H et al. Effects of cyclosporin on tubular acidification function in patients with idiopathic uveitis. Am J Nephrol 1992; 12: 425-430.
10. Kinugawa N, Okomoto Y, Ota S. Hyperkalemia in a cyclosporin A-treated allogeneic bone marrow transplant recipient. Jpn J Clin Hematol 1992; 33: 53-57.
11. Ethier J, Kamel K, Magner P et al. The transtubular potassium concentration in patients with hypokalemia and hyperkalemi. Am J Kid Dis 1990; 15: 309-315.
12. Laine J, Holmberg C. Renal and adrenal mechanisms in cyclosporin-induced hyperkalemia after renal transplantation. Eur J Clin Invest 1995; 25: 670-676.
13. Sebastian A, Schambelan M, Lindenfeld S, Morris R. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypodidosteronism. New Engl J Med 1977; 297: 576-583.